Global Diagnostic Radiopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Description

Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.

Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.

In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.

The global Diagnostic Radiopharmaceuticals market size is expected to reach $ 8217 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.

One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.

North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.

This report studies the global Diagnostic Radiopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Diagnostic Radiopharmaceuticals and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diagnostic Radiopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Diagnostic Radiopharmaceuticals total production and demand, 2019-2030, (K Dose)
Global Diagnostic Radiopharmaceuticals total production value, 2019-2030, (USD Million)
Global Diagnostic Radiopharmaceuticals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Dose), (based on production site)
Global Diagnostic Radiopharmaceuticals consumption by region & country, CAGR, 2019-2030 & (K Dose)
U.S. VS China: Diagnostic Radiopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Diagnostic Radiopharmaceuticals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Dose)
Global Diagnostic Radiopharmaceuticals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global Diagnostic Radiopharmaceuticals production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
This report profiles key players in the global Diagnostic Radiopharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Eli Lilly, China Isotope & Radiation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diagnostic Radiopharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Diagnostic Radiopharmaceuticals Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Diagnostic Radiopharmaceuticals Market, Segmentation by Type:
    Technetium 99
    Fluorine 18
    Other

Global Diagnostic Radiopharmaceuticals Market, Segmentation by Application:
    Oncology
    Cardiology
    Other

Companies Profiled:
    Cardinal Health
    GE Healthcare
    Jubilant Pharma
    Novartis
    Curium Pharma
    SIEMENS
    Lantheus
    Bracco Imaging
    Eli Lilly
    China Isotope & Radiation
    Dongcheng

Key Questions Answered:
1. How big is the global Diagnostic Radiopharmaceuticals market?
2. What is the demand of the global Diagnostic Radiopharmaceuticals market?
3. What is the year over year growth of the global Diagnostic Radiopharmaceuticals market?
4. What is the production and production value of the global Diagnostic Radiopharmaceuticals market?
5. Who are the key producers in the global Diagnostic Radiopharmaceuticals market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Diagnostic Radiopharmaceuticals Introduction
    1.2 World Diagnostic Radiopharmaceuticals Supply & Forecast
        1.2.1 World Diagnostic Radiopharmaceuticals Production Value (2019 & 2023 & 2030)
        1.2.2 World Diagnostic Radiopharmaceuticals Production (2019-2030)
        1.2.3 World Diagnostic Radiopharmaceuticals Pricing Trends (2019-2030)
    1.3 World Diagnostic Radiopharmaceuticals Production by Region (Based on Production Site)
        1.3.1 World Diagnostic Radiopharmaceuticals Production Value by Region (2019-2030)
        1.3.2 World Diagnostic Radiopharmaceuticals Production by Region (2019-2030)
        1.3.3 World Diagnostic Radiopharmaceuticals Average Price by Region (2019-2030)
        1.3.4 North America Diagnostic Radiopharmaceuticals Production (2019-2030)
        1.3.5 Europe Diagnostic Radiopharmaceuticals Production (2019-2030)
        1.3.6 China Diagnostic Radiopharmaceuticals Production (2019-2030)
        1.3.7 Japan Diagnostic Radiopharmaceuticals Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Diagnostic Radiopharmaceuticals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Diagnostic Radiopharmaceuticals Major Market Trends

2 Demand Summary
    2.1 World Diagnostic Radiopharmaceuticals Demand (2019-2030)
    2.2 World Diagnostic Radiopharmaceuticals Consumption by Region
        2.2.1 World Diagnostic Radiopharmaceuticals Consumption by Region (2019-2024)
        2.2.2 World Diagnostic Radiopharmaceuticals Consumption Forecast by Region (2025-2030)
    2.3 United States Diagnostic Radiopharmaceuticals Consumption (2019-2030)
    2.4 China Diagnostic Radiopharmaceuticals Consumption (2019-2030)
    2.5 Europe Diagnostic Radiopharmaceuticals Consumption (2019-2030)
    2.6 Japan Diagnostic Radiopharmaceuticals Consumption (2019-2030)
    2.7 South Korea Diagnostic Radiopharmaceuticals Consumption (2019-2030)
    2.8 ASEAN Diagnostic Radiopharmaceuticals Consumption (2019-2030)
    2.9 India Diagnostic Radiopharmaceuticals Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Diagnostic Radiopharmaceuticals Production Value by Manufacturer (2019-2024)
    3.2 World Diagnostic Radiopharmaceuticals Production by Manufacturer (2019-2024)
    3.3 World Diagnostic Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
    3.4 Diagnostic Radiopharmaceuticals Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Diagnostic Radiopharmaceuticals Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Diagnostic Radiopharmaceuticals in 2023
        3.5.3 Global Concentration Ratios (CR8) for Diagnostic Radiopharmaceuticals in 2023
    3.6 Diagnostic Radiopharmaceuticals Market: Overall Company Footprint Analysis
        3.6.1 Diagnostic Radiopharmaceuticals Market: Region Footprint
        3.6.2 Diagnostic Radiopharmaceuticals Market: Company Product Type Footprint
        3.6.3 Diagnostic Radiopharmaceuticals Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Diagnostic Radiopharmaceuticals Production Value Comparison
        4.1.1 United States VS China: Diagnostic Radiopharmaceuticals Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Diagnostic Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Diagnostic Radiopharmaceuticals Production Comparison
        4.2.1 United States VS China: Diagnostic Radiopharmaceuticals Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Diagnostic Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Diagnostic Radiopharmaceuticals Consumption Comparison
        4.3.1 United States VS China: Diagnostic Radiopharmaceuticals Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Diagnostic Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Diagnostic Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Diagnostic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Diagnostic Radiopharmaceuticals Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Diagnostic Radiopharmaceuticals Production (2019-2024)
    4.5 China Based Diagnostic Radiopharmaceuticals Manufacturers and Market Share
        4.5.1 China Based Diagnostic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Diagnostic Radiopharmaceuticals Production Value (2019-2024)
        4.5.3 China Based Manufacturers Diagnostic Radiopharmaceuticals Production (2019-2024)
    4.6 Rest of World Based Diagnostic Radiopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Diagnostic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production (2019-2024)

5 Market Analysis by Type
    5.1 World Diagnostic Radiopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Technetium 99
        5.2.2 Fluorine 18
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Diagnostic Radiopharmaceuticals Production by Type (2019-2030)
        5.3.2 World Diagnostic Radiopharmaceuticals Production Value by Type (2019-2030)
        5.3.3 World Diagnostic Radiopharmaceuticals Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Diagnostic Radiopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Oncology
        6.2.2 Cardiology
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Diagnostic Radiopharmaceuticals Production by Application (2019-2030)
        6.3.2 World Diagnostic Radiopharmaceuticals Production Value by Application (2019-2030)
        6.3.3 World Diagnostic Radiopharmaceuticals Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Cardinal Health
        7.1.1 Cardinal Health Details
        7.1.2 Cardinal Health Major Business
        7.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
        7.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Cardinal Health Recent Developments/Updates
        7.1.6 Cardinal Health Competitive Strengths & Weaknesses
    7.2 GE Healthcare
        7.2.1 GE Healthcare Details
        7.2.2 GE Healthcare Major Business
        7.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
        7.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 GE Healthcare Recent Developments/Updates
        7.2.6 GE Healthcare Competitive Strengths & Weaknesses
    7.3 Jubilant Pharma
        7.3.1 Jubilant Pharma Details
        7.3.2 Jubilant Pharma Major Business
        7.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
        7.3.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Jubilant Pharma Recent Developments/Updates
        7.3.6 Jubilant Pharma Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Diagnostic Radiopharmaceuticals Product and Services
        7.4.4 Novartis Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Curium Pharma
        7.5.1 Curium Pharma Details
        7.5.2 Curium Pharma Major Business
        7.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
        7.5.4 Curium Pharma Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Curium Pharma Recent Developments/Updates
        7.5.6 Curium Pharma Competitive Strengths & Weaknesses
    7.6 SIEMENS
        7.6.1 SIEMENS Details
        7.6.2 SIEMENS Major Business
        7.6.3 SIEMENS Diagnostic Radiopharmaceuticals Product and Services
        7.6.4 SIEMENS Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 SIEMENS Recent Developments/Updates
        7.6.6 SIEMENS Competitive Strengths & Weaknesses
    7.7 Lantheus
        7.7.1 Lantheus Details
        7.7.2 Lantheus Major Business
        7.7.3 Lantheus Diagnostic Radiopharmaceuticals Product and Services
        7.7.4 Lantheus Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Lantheus Recent Developments/Updates
        7.7.6 Lantheus Competitive Strengths & Weaknesses
    7.8 Bracco Imaging
        7.8.1 Bracco Imaging Details
        7.8.2 Bracco Imaging Major Business
        7.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
        7.8.4 Bracco Imaging Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Bracco Imaging Recent Developments/Updates
        7.8.6 Bracco Imaging Competitive Strengths & Weaknesses
    7.9 Eli Lilly
        7.9.1 Eli Lilly Details
        7.9.2 Eli Lilly Major Business
        7.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
        7.9.4 Eli Lilly Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Eli Lilly Recent Developments/Updates
        7.9.6 Eli Lilly Competitive Strengths & Weaknesses
    7.10 China Isotope & Radiation
        7.10.1 China Isotope & Radiation Details
        7.10.2 China Isotope & Radiation Major Business
        7.10.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
        7.10.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 China Isotope & Radiation Recent Developments/Updates
        7.10.6 China Isotope & Radiation Competitive Strengths & Weaknesses
    7.11 Dongcheng
        7.11.1 Dongcheng Details
        7.11.2 Dongcheng Major Business
        7.11.3 Dongcheng Diagnostic Radiopharmaceuticals Product and Services
        7.11.4 Dongcheng Diagnostic Radiopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Dongcheng Recent Developments/Updates
        7.11.6 Dongcheng Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Diagnostic Radiopharmaceuticals Industry Chain
    8.2 Diagnostic Radiopharmaceuticals Upstream Analysis
        8.2.1 Diagnostic Radiopharmaceuticals Core Raw Materials
        8.2.2 Main Manufacturers of Diagnostic Radiopharmaceuticals Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Diagnostic Radiopharmaceuticals Production Mode
    8.6 Diagnostic Radiopharmaceuticals Procurement Model
    8.7 Diagnostic Radiopharmaceuticals Industry Sales Model and Sales Channels
        8.7.1 Diagnostic Radiopharmaceuticals Sales Model
        8.7.2 Diagnostic Radiopharmaceuticals Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Diagnostic Radiopharmaceuticals Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Diagnostic Radiopharmaceuticals Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Diagnostic Radiopharmaceuticals Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Diagnostic Radiopharmaceuticals Production Value Market Share by Region (2019-2024)
 Table 5. World Diagnostic Radiopharmaceuticals Production Value Market Share by Region (2025-2030)
 Table 6. World Diagnostic Radiopharmaceuticals Production by Region (2019-2024) & (K Dose)
 Table 7. World Diagnostic Radiopharmaceuticals Production by Region (2025-2030) & (K Dose)
 Table 8. World Diagnostic Radiopharmaceuticals Production Market Share by Region (2019-2024)
 Table 9. World Diagnostic Radiopharmaceuticals Production Market Share by Region (2025-2030)
 Table 10. World Diagnostic Radiopharmaceuticals Average Price by Region (2019-2024) & (US$/Dose)
 Table 11. World Diagnostic Radiopharmaceuticals Average Price by Region (2025-2030) & (US$/Dose)
 Table 12. Diagnostic Radiopharmaceuticals Major Market Trends
 Table 13. World Diagnostic Radiopharmaceuticals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Dose)
 Table 14. World Diagnostic Radiopharmaceuticals Consumption by Region (2019-2024) & (K Dose)
 Table 15. World Diagnostic Radiopharmaceuticals Consumption Forecast by Region (2025-2030) & (K Dose)
 Table 16. World Diagnostic Radiopharmaceuticals Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Diagnostic Radiopharmaceuticals Producers in 2023
 Table 18. World Diagnostic Radiopharmaceuticals Production by Manufacturer (2019-2024) & (K Dose)
 Table 19. Production Market Share of Key Diagnostic Radiopharmaceuticals Producers in 2023
 Table 20. World Diagnostic Radiopharmaceuticals Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 21. Global Diagnostic Radiopharmaceuticals Company Evaluation Quadrant
 Table 22. World Diagnostic Radiopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Diagnostic Radiopharmaceuticals Production Site of Key Manufacturer
 Table 24. Diagnostic Radiopharmaceuticals Market: Company Product Type Footprint
 Table 25. Diagnostic Radiopharmaceuticals Market: Company Product Application Footprint
 Table 26. Diagnostic Radiopharmaceuticals Competitive Factors
 Table 27. Diagnostic Radiopharmaceuticals New Entrant and Capacity Expansion Plans
 Table 28. Diagnostic Radiopharmaceuticals Mergers & Acquisitions Activity
 Table 29. United States VS China Diagnostic Radiopharmaceuticals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Diagnostic Radiopharmaceuticals Production Comparison, (2019 & 2023 & 2030) & (K Dose)
 Table 31. United States VS China Diagnostic Radiopharmaceuticals Consumption Comparison, (2019 & 2023 & 2030) & (K Dose)
 Table 32. United States Based Diagnostic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Diagnostic Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Diagnostic Radiopharmaceuticals Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Diagnostic Radiopharmaceuticals Production (2019-2024) & (K Dose)
 Table 36. United States Based Manufacturers Diagnostic Radiopharmaceuticals Production Market Share (2019-2024)
 Table 37. China Based Diagnostic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Diagnostic Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Diagnostic Radiopharmaceuticals Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Diagnostic Radiopharmaceuticals Production, (2019-2024) & (K Dose)
 Table 41. China Based Manufacturers Diagnostic Radiopharmaceuticals Production Market Share (2019-2024)
 Table 42. Rest of World Based Diagnostic Radiopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production, (2019-2024) & (K Dose)
 Table 46. Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production Market Share (2019-2024)
 Table 47. World Diagnostic Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Diagnostic Radiopharmaceuticals Production by Type (2019-2024) & (K Dose)
 Table 49. World Diagnostic Radiopharmaceuticals Production by Type (2025-2030) & (K Dose)
 Table 50. World Diagnostic Radiopharmaceuticals Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Diagnostic Radiopharmaceuticals Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Diagnostic Radiopharmaceuticals Average Price by Type (2019-2024) & (US$/Dose)
 Table 53. World Diagnostic Radiopharmaceuticals Average Price by Type (2025-2030) & (US$/Dose)
 Table 54. World Diagnostic Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Diagnostic Radiopharmaceuticals Production by Application (2019-2024) & (K Dose)
 Table 56. World Diagnostic Radiopharmaceuticals Production by Application (2025-2030) & (K Dose)
 Table 57. World Diagnostic Radiopharmaceuticals Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Diagnostic Radiopharmaceuticals Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Diagnostic Radiopharmaceuticals Average Price by Application (2019-2024) & (US$/Dose)
 Table 60. World Diagnostic Radiopharmaceuticals Average Price by Application (2025-2030) & (US$/Dose)
 Table 61. Cardinal Health Basic Information, Manufacturing Base and Competitors
 Table 62. Cardinal Health Major Business
 Table 63. Cardinal Health Diagnostic Radiopharmaceuticals Product and Services
 Table 64. Cardinal Health Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Cardinal Health Recent Developments/Updates
 Table 66. Cardinal Health Competitive Strengths & Weaknesses
 Table 67. GE Healthcare Basic Information, Manufacturing Base and Competitors
 Table 68. GE Healthcare Major Business
 Table 69. GE Healthcare Diagnostic Radiopharmaceuticals Product and Services
 Table 70. GE Healthcare Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. GE Healthcare Recent Developments/Updates
 Table 72. GE Healthcare Competitive Strengths & Weaknesses
 Table 73. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
 Table 74. Jubilant Pharma Major Business
 Table 75. Jubilant Pharma Diagnostic Radiopharmaceuticals Product and Services
 Table 76. Jubilant Pharma Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Jubilant Pharma Recent Developments/Updates
 Table 78. Jubilant Pharma Competitive Strengths & Weaknesses
 Table 79. Novartis Basic Information, Manufacturing Base and Competitors
 Table 80. Novartis Major Business
 Table 81. Novartis Diagnostic Radiopharmaceuticals Product and Services
 Table 82. Novartis Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Novartis Recent Developments/Updates
 Table 84. Novartis Competitive Strengths & Weaknesses
 Table 85. Curium Pharma Basic Information, Manufacturing Base and Competitors
 Table 86. Curium Pharma Major Business
 Table 87. Curium Pharma Diagnostic Radiopharmaceuticals Product and Services
 Table 88. Curium Pharma Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Curium Pharma Recent Developments/Updates
 Table 90. Curium Pharma Competitive Strengths & Weaknesses
 Table 91. SIEMENS Basic Information, Manufacturing Base and Competitors
 Table 92. SIEMENS Major Business
 Table 93. SIEMENS Diagnostic Radiopharmaceuticals Product and Services
 Table 94. SIEMENS Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. SIEMENS Recent Developments/Updates
 Table 96. SIEMENS Competitive Strengths & Weaknesses
 Table 97. Lantheus Basic Information, Manufacturing Base and Competitors
 Table 98. Lantheus Major Business
 Table 99. Lantheus Diagnostic Radiopharmaceuticals Product and Services
 Table 100. Lantheus Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Lantheus Recent Developments/Updates
 Table 102. Lantheus Competitive Strengths & Weaknesses
 Table 103. Bracco Imaging Basic Information, Manufacturing Base and Competitors
 Table 104. Bracco Imaging Major Business
 Table 105. Bracco Imaging Diagnostic Radiopharmaceuticals Product and Services
 Table 106. Bracco Imaging Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Bracco Imaging Recent Developments/Updates
 Table 108. Bracco Imaging Competitive Strengths & Weaknesses
 Table 109. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 110. Eli Lilly Major Business
 Table 111. Eli Lilly Diagnostic Radiopharmaceuticals Product and Services
 Table 112. Eli Lilly Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Eli Lilly Recent Developments/Updates
 Table 114. Eli Lilly Competitive Strengths & Weaknesses
 Table 115. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
 Table 116. China Isotope & Radiation Major Business
 Table 117. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product and Services
 Table 118. China Isotope & Radiation Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. China Isotope & Radiation Recent Developments/Updates
 Table 120. China Isotope & Radiation Competitive Strengths & Weaknesses
 Table 121. Dongcheng Basic Information, Manufacturing Base and Competitors
 Table 122. Dongcheng Major Business
 Table 123. Dongcheng Diagnostic Radiopharmaceuticals Product and Services
 Table 124. Dongcheng Diagnostic Radiopharmaceuticals Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Dongcheng Recent Developments/Updates
 Table 126. Dongcheng Competitive Strengths & Weaknesses
 Table 127. Global Key Players of Diagnostic Radiopharmaceuticals Upstream (Raw Materials)
 Table 128. Global Diagnostic Radiopharmaceuticals Typical Customers
 Table 129. Diagnostic Radiopharmaceuticals Typical Distributors


List of Figures
 Figure 1. Diagnostic Radiopharmaceuticals Picture
 Figure 2. World Diagnostic Radiopharmaceuticals Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Diagnostic Radiopharmaceuticals Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Diagnostic Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 5. World Diagnostic Radiopharmaceuticals Average Price (2019-2030) & (US$/Dose)
 Figure 6. World Diagnostic Radiopharmaceuticals Production Value Market Share by Region (2019-2030)
 Figure 7. World Diagnostic Radiopharmaceuticals Production Market Share by Region (2019-2030)
 Figure 8. North America Diagnostic Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 9. Europe Diagnostic Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 10. China Diagnostic Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 11. Japan Diagnostic Radiopharmaceuticals Production (2019-2030) & (K Dose)
 Figure 12. Diagnostic Radiopharmaceuticals Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 15. World Diagnostic Radiopharmaceuticals Consumption Market Share by Region (2019-2030)
 Figure 16. United States Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 17. China Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 18. Europe Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 19. Japan Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 20. South Korea Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 21. ASEAN Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 22. India Diagnostic Radiopharmaceuticals Consumption (2019-2030) & (K Dose)
 Figure 23. Producer Shipments of Diagnostic Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Diagnostic Radiopharmaceuticals Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Diagnostic Radiopharmaceuticals Markets in 2023
 Figure 26. United States VS China: Diagnostic Radiopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Diagnostic Radiopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Diagnostic Radiopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Diagnostic Radiopharmaceuticals Production Market Share 2023
 Figure 30. China Based Manufacturers Diagnostic Radiopharmaceuticals Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Diagnostic Radiopharmaceuticals Production Market Share 2023
 Figure 32. World Diagnostic Radiopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Diagnostic Radiopharmaceuticals Production Value Market Share by Type in 2023
 Figure 34. Technetium 99
 Figure 35. Fluorine 18
 Figure 36. Other
 Figure 37. World Diagnostic Radiopharmaceuticals Production Market Share by Type (2019-2030)
 Figure 38. World Diagnostic Radiopharmaceuticals Production Value Market Share by Type (2019-2030)
 Figure 39. World Diagnostic Radiopharmaceuticals Average Price by Type (2019-2030) & (US$/Dose)
 Figure 40. World Diagnostic Radiopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World Diagnostic Radiopharmaceuticals Production Value Market Share by Application in 2023
 Figure 42. Oncology
 Figure 43. Cardiology
 Figure 44. Other
 Figure 45. World Diagnostic Radiopharmaceuticals Production Market Share by Application (2019-2030)
 Figure 46. World Diagnostic Radiopharmaceuticals Production Value Market Share by Application (2019-2030)
 Figure 47. World Diagnostic Radiopharmaceuticals Average Price by Application (2019-2030) & (US$/Dose)
 Figure 48. Diagnostic Radiopharmaceuticals Industry Chain
 Figure 49. Diagnostic Radiopharmaceuticals Procurement Model
 Figure 50. Diagnostic Radiopharmaceuticals Sales Model
 Figure 51. Diagnostic Radiopharmaceuticals Sales Channels, Direct Sales, and Distribution
 Figure 52. Methodology
 Figure 53. Research Process and Data Source

Companies Mentioned

Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng